Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.33 |
| ▸ | RXRA | P19793 | 2/20 | 0.31 |
| ▸ | RXRB | P28702 | 2/20 | 0.31 |
| ▸ | RXRG | P48443 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22934104 | 0.93 | AHR (0.32) | RXRARXRBRXRGMEN1CYP2C19 | |
| SCHEMBL22937935 | 0.90 | PGR (0.31) | RXRARXRBRXRG | |
| SCHEMBL23439071 | 0.86 | AHR (0.33) | RXRARXRBRXRGMEN1KMT2A | |
| SCHEMBL22936267 | 0.86 | MEN1 (0.32) | MEN1KMT2A | |
| SCHEMBL22933929 | 0.85 | RXRA (0.33) | RXRARXRBRXRG | |
| SCHEMBL24771788 | 0.83 | MEN1 (0.31) | RXRARXRBRXRGMEN1CYP2C19 | |
| SCHEMBL22949220 | 0.83 | — | — | |
| SCHEMBL23440006 | 0.81 | MEN1 (0.31) | RXRARXRBRXRGMEN1CYP2C19 | |
| SCHEMBL29331120 | 0.81 | RARA (0.37) | ALOX5RXRARXRBRXRGMEN1 | |
| SCHEMBL26308240 | 0.81 | RARA (0.37) | ALOX5RXRARXRBRXRGMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021107711-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | 주식회사 엘지화학 | 2021-06-03 | — | — | WO | disclosed |
| WO-2021020931-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2021-02-04 | — | — | WO | disclosed |